15-Deoxy-Delta(12,14)-Prostaglandin J(2) Inhibits Osteolytic BreastCancer Bone Metastasis and Estrogen Deficiency-Induced Bone Loss

Collection with item attached
2015
Item details URL
http://open-repository.kisti.re.kr/cube/handle/open_repository/473405.do
DOI
10.1371/journal.pone.0122764
Title
15-Deoxy-Delta(12,14)-Prostaglandin J(2) Inhibits Osteolytic BreastCancer Bone Metastasis and Estrogen Deficiency-Induced Bone Loss
Description
This work was supported by a faculty research grant from YonseiUniversity College of Dentistry for 2009 (6-2009-0025). The funders hadno role in study design, data collection and analysis, decision topublish, or preparation of the manuscript.
abstract
Breast cancer is the major cause of cancer death in women worldwide. The most common site of metastasis is bone. Bone metastases obstruct the normal bone remodeling process and aberrantly enhance osteoclast-mediated bone resorption, which results in osteolytic lesions. 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) is an endogenous ligand of peroxisome proliferator-activated receptor gamma (PPAR.) that has anti-inflammatory and antitumor activity at micromolar concentrations through PPAR.-dependent and/or PPAR.-independent pathways. We investigated the inhibitory activity of 15d-PGJ(2) on the bone loss that is associated with breast cancer bone metastasis and estrogen deficiency caused by cancer treatment. 15d-PGJ2 dose-dependently inhibited viability, migration, invasion, and parathyroid hormone-related protein (PTHrP) production in MDA-MB-231 breast cancer cells. 15d-PGJ(2) suppressed receptor activator of nuclear factor kappa-B ligand (RANKL) mRNA levels and normalized osteoprotegerin (OPG) mRNA levels in hFOB1.19 osteoblastic cells treated with culture medium from MDA-MB-231 cells or PTHrP, which decreased the RANKL/OPG ratio. 15d-PGJ(2) blocked RANKL-induced osteoclastogenesis and inhibited the formation of resorption pits by decreasing the activities of cathepsin K and matrix metalloproteinases, which are secreted by mature osteoclasts. 15d-PGJ(2) exerted its effects on breast cancer and bone cells via PPAR.-independent pathways. In Balb/c nu/nu mice that received an intracardiac injection of MDA-MB-231 cells, subcutaneously injected 15d-PGJ(2) substantially decreased metastatic progression, cancer cell-mediated bone destruction in femora, tibiae, and mandibles, and serum PTHrP levels. 15d-PGJ(2) prevented the destruction of femoral trabecular structures in estrogen-deprived ICR mice as measured by bone morphometric parameters and serum biochemical data. Therefore, 15d-PGJ(2) may be beneficial for the prevention and treatment of breast cancer-associated
provenance
Made available in Cube on 2018-09-28T10:18:37Z (GMT). No. of bitstreams: 0
language
English
author
Kim, Ki Rim
Kim, Hyun Jeong
Lee, Sun Kyoung
Ma, Gwang Taek
Park, Kwang Kyun
Chung, Won Yoon
accessioned
2018-09-28T10:18:37Z
available
2018-09-28T10:18:37Z
issued
2015
citation
PLOS ONE(10): 4
issn
1932-6203
uri
http://open-repository.kisti.re.kr/cube/handle/open_repository/473405.do
Funder
교육부
Funding Program
BK21플러스사업
Project ID
1345244268
Jurisdiction
Rep.of Korea
Project Name
Interdisciplinary Oral Science Graduate Program
rights
openAccess
type
article


Files in This Item

There are no attached files.